Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
KOOL

Cesca Therapeutics

$0.48

0.0068 (1.45%)

08:48
06/04/18
06/04
08:48
06/04/18
08:48
Hot Stocks
Cesca Therapeutics announces reduction in operating expenses »

Cesca Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QTNA

Quantenna Communications

$15.66

0.72 (4.82%)

, KOOL

Cesca Therapeutics

$0.54

0.0091 (1.71%)

10:33
05/23/18
05/23
10:33
05/23/18
10:33
Initiation
On The Fly: Top five analyst initiations »

Catch up on today's…

QTNA

Quantenna Communications

$15.66

0.72 (4.82%)

KOOL

Cesca Therapeutics

$0.54

0.0091 (1.71%)

WTI

W&T Offshore

$8.26

-0.09 (-1.08%)

TAST

Carrols Restaurant

$11.70

0.05 (0.43%)

VNDA

Vanda Pharmaceuticals

$17.05

0.5 (3.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Jun

KOOL

Cesca Therapeutics

$0.53

0.0307 (6.14%)

07:04
05/23/18
05/23
07:04
05/23/18
07:04
Initiation
Cesca Therapeutics initiated at H.C. Wainwright »

Cesca Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Over a month ago
KOOL

Cesca Therapeutics

$1.60

-0.04 (-2.44%)

08:34
04/24/18
04/24
08:34
04/24/18
08:34
Hot Stocks
Cesca announces evaluation agreement with University of North Carolina »

Cesca Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KOOL

Cesca Therapeutics

$1.59

(0.00%)

08:32
04/17/18
04/17
08:32
04/17/18
08:32
Hot Stocks
Cesca Therapeutics announces first evaluation agreement for X-Series products »

Cesca Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KOOL

Cesca Therapeutics

$1.66

-0.01 (-0.60%)

16:36
04/06/18
04/06
16:36
04/06/18
16:36
Syndicate
Breaking Syndicate news story on Cesca Therapeutics »

Cesca Therapeutics files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Over a quarter ago
KOOL

Cesca Therapeutics

$2.81

0.06 (2.18%)

07:07
03/19/18
03/19
07:07
03/19/18
07:07
Hot Stocks
Cesca Therapeutics files new patent covering cell activation, transduction »

Cesca Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Mar

KOOL

Cesca Therapeutics

$3.05

-0.0196 (-0.64%)

07:19
03/14/18
03/14
07:19
03/14/18
07:19
Hot Stocks
Cesca Therapeutics subsidiary expands CAR-T related CDMO services »

Cesca Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KOOL

Cesca Therapeutics

$2.86

-0.03 (-1.04%)

07:05
02/26/18
02/26
07:05
02/26/18
07:05
Hot Stocks
Cesca Therapeutics announces launch of AXP II »

Cesca Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KOOL

Cesca Therapeutics

$2.64

0.07 (2.72%)

17:24
02/12/18
02/12
17:24
02/12/18
17:24
Syndicate
Cesca Therapeutics requests withdrawal of registration statement »

The company submits this…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.